Gene Query: TNFRSF1B

Dataset Description Geneva Score
SUV420H2 knockdown in PANC-1 137.21
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 120.35
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 90.98
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 86.48
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 86.48
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 72.22
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 66.13
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 53.16
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 50.82
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 47.94
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 45.85
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 45.22
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 45.22
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 43.71
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 42.72
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 41.24
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 40.12
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 39.94
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 39.11
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 39.0
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 39.0
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 37.81
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 36.76
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 35.97
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 35.35
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 34.69
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 34.23
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 32.87
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 32.87
naive T cell heterogeneity after neonatal thymectomy 32.54
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 31.76
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 31.76
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 31.18
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 30.84
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 30.67
MicroRNA-125a-5p overexpression in human macrophages 30.45
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 29.68
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 29.58
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 29.58
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 28.85
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 28.85
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 27.73
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 27.7
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 27.7
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 27.68
Nutritional control of protein translation 27.45
The role of FAM46C in myeloma cells [sequencing] 27.09
The role of FAM46C in myeloma cells 27.09
Transcriptional profiles of normal human mature B cells 26.63
Transcriptomic analysis of human tonsillar TFH subsets 26.04
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 25.92
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 25.92
Differential gene expression profiles in imatinib-resistant cell lines 25.09
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 24.42
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 23.61
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 23.43
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 23.3
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 23.25
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 22.13
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 21.91
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 21.17
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 21.17
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 20.91
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 20.02
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 19.62
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 19.58
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 19.54
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 19.44
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 19.38
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 19.28
RNA-seq of stable and unstable section of human atherosclerotic plaques 18.92
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 18.91
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 18.91
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 18.83
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 18.83
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 18.78
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 18.5
Spliceosomal disruption of the non-canonical BAF complex in cancer 18.38
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 18.2
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 17.83
Trans-differentiation of human adult peripheral blood T cells into neurons 17.81
TCF7L1 knockdown in pancreatic cancer 17.6
Fbxo32 mediated gene expression program underlies EMT and metastasis 17.38
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 17.27
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 17.03
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 16.99
Crizotinib v. DMSO in SW480 cells 16.75
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 16.75
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 16.69
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 16.69
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 16.56
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 16.53
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 16.32
Transcriptome of EBV-infected gastric cancer cell lines 16.32
Pharmacologic inhibition of STAT5 in AML 16.23
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 16.09
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 16.07
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 16.05
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 16.04
CircRNAome diversity in human mature B-cells, T-cells and monocytes 15.9
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 15.78
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 15.49
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 15.46
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 15.39
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 15.33
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 15.25
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 15.01
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 15.01
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.99
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.99
Human neutrophil genome during PMA- and E. coli encounter-induced activation 14.83
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 14.83
Short and Long RNA sequencing of human mature erythrocytes 14.82
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 14.74
CHD1 regulates cell fate determination by activation of differentiation-induced genes 14.64
Statins modulate endothelial transcriptional profile by inhibiting EZH2 14.59
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 14.58
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 14.46
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 14.4
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 14.27
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 14.27
RNA-seq analysis of differentiating human erythroblasts 14.16
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 14.11
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 14.07
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 13.87
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 13.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 13.85
Efficient derivation of microglia-like cells from human pluripotent stem cells 13.58
Microglia innatly develop within cerebral organoids 13.56
Effect of PRDM11 depletion in U2932 cells 13.38
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 13.31
Peptidomimetic blockade of MYB in acute myeloid leukemia 13.31
Tumor exosome integrins determine organotropic metastasis 13.31
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 13.22
Global analysis of alternative splicing regulated by RBM10 13.2
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 13.18
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 13.14
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 12.93
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 12.78
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 12.78
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 12.67
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 12.62
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 12.53
RNA splicing alteration on glioblastoma and normal neural stem cells 12.52
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 12.5
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 12.33
SRSF2 mutations impair hematopoiesis and alter exon recognition 12.31
Effect of mitochondria deficiency on senescence-associated gene expression 12.23
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 12.17
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 12.11
Widespread regulated alternative splicing of single codons accelerates proteome evolution 11.94
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 11.83
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 11.74
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 11.7
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 11.54
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 11.5
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 11.5
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 11.47
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 11.35
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 11.25
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 11.23
Integrating single-cell transcriptomic data across different conditions, technologies, and species 11.21
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 11.18
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 11.18
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 11.11
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 11.08
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 11.0
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 11.0
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.98
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.98
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 10.91
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 10.89
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 10.81
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 10.81
RNA-seq analysis of AML cells in response to ASLAN003 10.8
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 10.79
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.57
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 10.56
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 10.47
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 10.42
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 10.33
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 10.3
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.29
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 10.28
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 10.21
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.12
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 10.12
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 10.12
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 10.08
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 10.07
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 10.06
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 10.06
mRNA expression profile of Lymphocytes 10.01
CD74 role in transcription regulation [RNA-seq] 9.99
CD74 role in transcription regulation 9.99
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 9.92
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 9.82
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 9.79
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 9.77
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 9.75
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 9.7
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 9.7
circRNA profile in hypopharyngeal cancer 9.7
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 9.67
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 9.67
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 9.38
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 9.38
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 9.36
MYCi975 regulates MYC target genes 9.35
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 9.34
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 9.33
Accurate annotation of human protein-coding small open reading frames 9.33
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 9.28
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 9.25
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.24
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.24
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 9.19
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 9.15
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 9.06
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 9.0
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 8.99
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 8.93
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 8.91
Intrahepatic MAIT cell gene expression revealed by RNA-seq 8.81
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 8.66
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 8.64
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.56
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 8.54
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.52
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.52
Endothelial gene expression analysis 8.42
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 8.42
Be1 and Be2 B cells are transcriptionally distinct 8.29
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 8.27
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 8.27
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 8.25
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 8.25
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.2
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 8.18
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.18
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 8.16
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 8.15
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 8.13
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.1
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 8.06
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 8.04
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.04
Human Treg NaCl stimulation 7.9
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 7.85
Selective suppression of endothelial cytokine production by progesterone receptor 7.85
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 7.82
JAK dependent survival of ALK- ALCL 7.79
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 7.74
Single-Cell Genotyping of Transcriptomes 7.66
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.66
Primary human trophoblast from term placenta 7.65
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 7.6
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.59
Direct Isolation and Characterization of Human Nephron Progenitors. 7.44
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.43
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.43
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 7.41
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 7.4
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 7.39
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 7.32
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 7.26
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 7.18
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.18
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.18
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 7.09
Reprogrammed myeloid cell transcriptomes in NSCLC 7.09
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 7.08
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.0
Aging-associated patterns in the expression of human endogenous retroviruses 6.99
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 6.9
A map of gene expression in neutrophil-like cell lines 6.81
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.78
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 6.77
RNA-seq analysis of the human fetal kidney. 6.72
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.68
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.68
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 6.63
Leucegene: AML sequencing (part 6) 6.62
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.61
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 6.58
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 6.52
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 6.49
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 6.46
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 6.46
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 6.46
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 6.45
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 6.42
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.35
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.34
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.34
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 6.32
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 6.27
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 6.27
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.21
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.1
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 6.05
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 6.05
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.04
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.99
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 5.75
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 5.74
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.71
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.71
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.7
RNA-Seq from human ILC transitional populations 5.7
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.46
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 5.45
RNA-sequencing of human tendon after injury 5.42
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 5.4
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 5.4
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 5.39
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.39
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 5.37
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.37
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.35
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.32
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 5.29
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 5.28
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.22
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 5.17
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 5.13
RNA editing in nascent RNA affects pre-mRNA splicing 5.11
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.1
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 5.09
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 5.01
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.0
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 4.93
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 4.93
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.9
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.86
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 4.86
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 4.85
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.85
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.84
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.81
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.77
Transcription control by the ENL YEATS domain in acute leukemia 4.75
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.75
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 4.71
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.65
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.65
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 4.38
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.38
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 4.34
Identification of renal resident macrophages across species 4.33
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 4.32
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 4.26
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 4.22
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 4.2
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.17
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 4.14
RNA-seq in endometrial stromal tumors 4.07
circNFIB suppresses lymphatic metastasis of pancreatic cancer 4.06
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.04
Human Treg IFNg/IL-10 subpopulations 3.96
RNA-seq data 3.93
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 3.87
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.87
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.86
Total RNA-Seq data from leukemic patients with complex structural variants 3.81
Leucegene: ALL sequencing 3.8
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 3.77
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.75
Unique features and clinical importance of acute alloreactive immune responses 3.74
RNA expression profiles comparing primary and omental ovarian carcinoma samples 3.69
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.68
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.68
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.64
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.61
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.57
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.57
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.57
3.52
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.51
Human optic chiasm from healthy controls and multiple sclerosis patients 3.48
Multiple sclerosis and EAE 3.48
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 3.48
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 3.48
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.45
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 3.44
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.43
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.4
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.4
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.39
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 3.36
Hepatosplenic T cell lymphoma 3.36
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 3.32
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.23
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.23
Common inflammatory pathways between NEC and Crohn's disease 3.0
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 2.92
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.88
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.87
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.84
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.68
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 2.62
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.54
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.51
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 2.49
The role of m6A/m-RNA methylation in stress response regulation 2.49
Transcriptomes in healthy and CHB fetal hearts 2.48
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 2.46
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.46
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.45
Evaluating pre-clinical models for studying NASH driven HCC. 2.44
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.43
Gene expression activation in CLL mediated by MSCs contact 2.41
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.41
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 2.38
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.37
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.29
Transcriptome analysis of peripheral blood monocytes 2.2
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.15
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.12
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.06
Deep RNA sequencing of the human placental transcriptome 2.01
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.99
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.97
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.96
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.93
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.82
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.82
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.82
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.75
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.75
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.73
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.73
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.72
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.71
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.7
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.66
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.58
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.49
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.41
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.4
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.4
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.39
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.39
Hepatic transcriptome of pediatric hepatoblastoma. 1.37
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.36
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.36
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.36
Measure transcript integrity using RNA-seq data 1.34
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.32
Characterization of human ILC2 subsets 1.3
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.29
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.28
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.27
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.27
oxLDL exposed trained monocytes 1.2
Transcriptomes of oxLDL exposed trained monocytes 1.2
Clinker: visualizing fusion genes detected in RNA-seq data 1.19
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 1.15
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.15
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.14
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.98
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.98
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.96
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.96
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.95
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.95
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.95
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.94
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.91
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.89
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.83
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.83
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.8
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.79
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.76
RNA-seq of CD33 KO and control HSPCs 0.76
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.75
The transcriptome of Kawasaki Disease arteritis 0.74
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.74
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.61
Molecular analysis of renal cell carcinoma with unclassfied histology 0.61
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.54
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.52
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.52
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.47
Transcriptome sequencing of K-562 cells 0.44
RNA sequencing of human pancreatic cancer cell lines 0.42
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.38
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.32
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.24
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.22
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.21
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.2
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.14
Specific molecular signatures underlie response to decitabine in CMML 0.13
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.13
Identification of renal resident macrophages across species [C1] 0.08
Human ovarian granulosa cell transcriptome 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation